Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » 10X Genomics

10X Genomics

 

10x Genomics, Inc. is an American company incorporated in 2012 that develops and manufactures integrated systems for whole genome sequencing, exome sequencing and single cell transcriptomics. Its headquarters are located in Pleasanton, California.

 

10X Genomics Company Profile  

 

President & CEO: Serge Saxonov

CEO photo:

 10X Genomics CEO photo - Serge Saxonov

Website: http://10xgenomics.com

Headquarters: Pleasanton, CA

10x Genomics employees: 101-250

Funding: $113M USD

Founded: 2012

Founders: Serge Saxonov, Ben Hindson


 

10x Genomics News 

May 21, 2020

Genomic, Synthetic Bio Platforms Power COVID-19 Antibody Discovery at Vanderbilt Lab

Premium

Single-cell analysis, next-generation sequencing, and synthetic DNA have all been crucial to efforts to find antibodies that could neutralize SARS-CoV-2.

May 18, 2020

10x Genomics Countersues Bio-Rad Laboratories in Latest Patent Infringement Lawsuit

10x asked the US District Court for the Northern District of California to dismiss a suit, while another district court judge denied a 10x motion to dismiss.

May 11, 2020

10x Genomics Q1 Revenues Increase 34 Percent

The Pleasanton, California-based firm reported $71.9 million in revenues but missed the consensus Wall Street estimates for quarterly revenues as well as loss per share.

Apr 29, 2020

Pan-Cancer Screening Tests Report First Performance Numbers in Undiagnosed Cohorts

Premium

At the AACR annual meeting, researchers shared detection rate data for multi-cancer screening tests from Grail and Thrive Earlier Detection.

Apr 14, 2020

New Studies Compare, Set Benchmarks for Single-Cell RNA Sequencing Methods

Premium

Both studies emerged from the ongoing Human Cell Atlas project and could help scientists decide on the best approaches to use in various contexts.

Apr 09, 2020

10x Genomics Anticipates 33 Percent Q1 Revenue Increase, Withdraws 2020 Guidance

The company reported preliminary Q1 revenues of $71 million to $72 million, despite a decline in customer activity due to the coronavirus pandemic.

Apr 09, 2020

Bio-Rad Laboratories Acquires Single-Cell Analysis Firm Celsee

Ann Arbor, Michigan-based Celsee offers instruments and consumables for isolating, detecting, and analyzing single cells.

Apr 03, 2020

People in the News: Kim Popovits, Miles Harrison, Matt Sargent, More

Mar 27, 2020

10x Genomics Joins Single-Cell Multi-Omics Alliance to Develop Antibody Therapies for Coronavirus

The alliance, led by Singapore-based startup Proteona, also includes several organizations from that city state as well as German research institutes.

Feb 25, 2020

10x Genomics Unveils 2020 New Product Pipeline at AGBT

Premium

The company plans to offer four new products by the end of the year, including four targeted transcriptomic panels and IHC compatibility for Visium.

Pages

The Scan

Preprints During Lockdown

New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

ApoE and COVID-19

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

Search for Genetic Clues to COVID-19 Severity

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

PNAS Papers on Retinal Development, Adoptive T Cell Transfer, Blood Cell Differentiation

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.

What's Popular?

In 10X Genomics

  1. Genomic, Synthetic Bio Platforms Power COVID-19 Antibody Discovery at Vanderbilt Lab

    Premium

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.